Widespread RNA editing changes in patients with autism

Widespread RNA editing changes in patients with autism
 

A team of scientists has discovered important clues to what goes wrong in the brains of people with autism -- a developmental disorder with no cure and for which scientists have no deep understanding of what causes it.

The new insights involve RNA editing -- in which genetic material is normal, but modifications in RNA alter nucleotides, whose patterns carry the data required for constructing proteins.

"RNA editing is probably having a substantial physiologic effect in the brain, but is poorly understood," said co-author. "RNA editing is a mysterious area whose biological implications have not been much explored. We know what only a handful of these RNA editing sites do to proteins. This study gives a new critical clue in understanding what has gone awry in the brains of autism patients."

The researchers analyzed brain samples from 69 people who died, about half of whom had autism spectrum disorder (which includes autism and related conditions), and about half of whom did not and served as a control group.

The research team analyzed seven billion nucleotides for each brain sample. The team discovered reduced editing in the group members with autism. Specifically, they identified 3,314 editing sites in the brain's frontal cortex in which the autism patients had different levels of RNA editing from the control group. In 2,308 of those sites, the individuals with autism had reduced RNA editing, said lead author. In the 1,006 others, they had increased levels of RNA editing.

In the brain's temporal cortex, the people with autism had different levels of RNA editing from the control group in 2,412 editing sites, with 1,471 of those sites showing reduced editing levels. In the brain's cerebellum, the autism group members had different levels of RNA editing from control group members in 4,340 sites, of which 3,330 sites in the autistic brain had decreased levels. All three of these brain regions are very important in autism.

The research, published in the journal Nature Neuroscience, is the first comprehensive study of RNA editing in autism spectrum disorder.The author said RNA editing can be thought of as RNA mutations, analogous to the DNA mutations that are linked to many diseases.

"The same piece of DNA can generate multiple versions of RNA, and possibly lead to different protein sequences," said the author. "RNA editing allows cells to create novel protein sequences that are not written in the DNA."

In another major finding, the researchers identified two proteins, called FMRP and FXR1P, that regulate abnormal RNA editing in autism spectrum disorder. FMRP increases RNA editing and FXR1P decreases RNA editing. The autism group had reduced editing levels regulated by FMRP, as well as reduced RNA editing overall.

"This is the first strong data showing a broad and direct functional role for FMRP and FXR1P in the human brain and autism," the author said.

RNA editing may also be disrupted in schizophrenia, bipolar disorder and major depression. The research team plans to continue to study this as well as other brain diseases.

The team replicated their findings by analyzing the frontal cortex from a different group of 22 people who had autism spectrum disorder and a control group of 23 without the disorder. They found the same pattern of editing reduction as they found originally, author said.

The researchers found RNA editing alterations in genes of critical neurological relevance to autism, including CNTNAP2 and CNTNAP4, NRXN1 and NRXN3, ANK2, NOVA1 and RBFOX1.

https://www.nature.com/articles/s41593-018-0287-x

Edited

Rating

Unrated